false
Hamburger Menu
Catalog
How Did Toxicology Become Our Most Profitable Anci ...
How Did Toxicology Become Our Most Profitable Ancillary?
Description
Join us for a case study of how our clinic have used toxicology (UA-Urine Analysis) to not only assist in the management of opioid use for patient, but to generate additional income. How our clinic evolved from just collecting UAs, to collecting and screening UAs to the collecting screening and confirmation of UAs.
Learning Objectives:
1) Determine if this is an opportunity for your clinic
2) Describe the pros and cons of toxicology in pain management & orthopedics
3) Recognize the varying progressive levels of toxicology services.
Speaker:
Chris Greenman, CEO, Vail Summit Orthopaedics and Neurosurgery
Chris Greenman has been in orthopedic group practice for over 26 years. For the first 24 years, he was the CEO for Tahoe Fracture & Orthopedic Medical Clinic. Since 2023, Chris has been the CEO of Vail Summit Orthopaedic and Neurosurgery. He has overseen the addition of several ancillaries including ASCs, MRIs, DME and Lab. He has also headed up the design and construction of medical office buildings, and mergers & acquisitions to name a few. Greenman enjoys that aspect of working with others and helping them find and reach their potential.
Summary
Availability:
On-Demand
Cost:
Member: $0.00
Non-Member: $25.00
Credit Offered:
No Credit Offered
×
How Did Toxicology Become Our Most Profitable Ancillary? Course List
Create Account
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English